INTRODUCTION
(Glostrup, Denmark).
ECL Western blotting detection system was from Amersham (Buckinghamshire, England).
X-Omat AR imaging film was from Kodak (Rochester, NY, USA). Molecular weight standards for gel permeation chromatography were purchased from Amersham Pharmacia Biotech.
METHODS
Non-reducing urea-SDS-polyacrylamide gel electrophoresis Serum was diluted in 200 volumes of the sample treatment buffer (50mM Tris-HCl, pH6.8, 6M urea, 2% (w/v) SDS). Urine was diluted in 2 volumes of the same buffer. The diluted samples were incubated for 3 through the incubation in the buffer that was free from any reducing agent.
Ten-microliter aliquots of the pre-treated samples were applied to 15%T-3%C or 7.5%T-5%C polyacrylamide gel slab. Colored protein standards were applied into the next well to samples for calibration of molecular mass. Electrophoresis was carried out at 200V in the Tris-HCl-Tricine buffer system8) in which 0.2M Tris-HCl (pH8. 8) and 50mM Tris, 50mM Tricine, 0.1% (w/v) SDS (pH not adjusted) were used for anodic and cathodic electrolytes, respectively. The vertical slab gel electrophoresis apparatus (model 3065) and programmable power supply (model 3800) were purchased from Anatech (Tokyo, Japan).
Western blotting
After electrophoresis, proteins were transferred to a PVDF membrane at 5V/cm for 2h using an electrotransfer blotting apparatus (model KS-8442) purchased from MARYSOL (Tokyo, Japan). The membrane was rinsed briefly in distilled water, and incubated in TTBS (50mM Tris-HCl, pH7.5, 0.1M NaCl, 0.5% (v/v) Tween-20) supplemented with 5% (w/v) skim milk for blocking nonspecific adsorption of antibody. The membrane was then incubated with 1:1,000 dilution of in TTBS. After incubation, the membrane was washed three times with TTBS, then treated with ECL reagent for 1min. Peroxidase activity was visualized on the X-Omat imaging film by chemiluminescent exposure. Gel permeation chromatography Gel permeation chromatography of IgA molecule in the native condition was performed on a FPLC system equipped with a Superose 12 column. A 10ml aliquot of serum was applied to the column equilibrated with TBS (50mM Tris-HCl, pH7.5, 0.15M NaCl). Effluent was collected in 0.2ml each fractions, and the abnormal IgA molecule was detected by the non-reducing urea-SDS-PAGE. Relative molecular mass was calibrated using molecular weight standards. The chromatography was performed on a Superose column equilibrated with Tris-buffered saline. Fractions (0.2ml each) of the effluent were collected and IgA molecules in fractions were separated by urea-SDS-PAGE on a 15%T-3%C gel slab. Methods used for protein detection: Coomassie staining (A); Immunoblotting with anti-l-chain antibody (B); Western blot- Table 1 . Biochemical data in monoclonal IgA gammopathy patients.
* The urinary protein concentration in mg/dl of this patient was not determined. ** Lower than 10mg/dl.
